QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.055905v1 307/2/676    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chen, S.-R. Articles by Pan, H.-L. Search for Related Content PubMed PubMed Citation Articles by Chen, S.-R. Articles by Pan, H.-L.

NEUROPHARMACOLOGY

Up-Regulation of Spinal Muscarinic Receptors and Increased Antinociceptive Effect of Intrathecal Muscarine in Diabetic Rats

Department of Anesthesiology (S.-R. C., H.-L. P.) and the Department of Neural and Behavioral Sciences (H.-L. P.), The Pennsylvania State University College of Medicine, The Milton S. Hershey Medical Center, Hershey, Pennsylvania

Spinally administered muscarinic receptor agonists or acetylcholinesterase inhibitors produce effective pain relief. Intrathecal injection of a small dose of neostigmine produces a profound antiallodynic effect in rats with diabetic neuropathy. However, the mechanisms of increased antinociceptive effect of cholinergic agents on diabetic neuropathic pain are not clear. In the present study, we tested the hypothesis that spinal muscarinic receptors are up-regulated in diabetes. The withdrawal threshold of the hindpaw in response to noxious heat and pressure stimuli was determined in streptozotocin-induced diabetic and age-matched normal rats. Muscarine-stimulated guanosine 5'-O-(3-[³⁵S]thio)triphosphate ([³⁵S]GTPS) binding was used to assess the change of functional muscarinic receptors in the spinal cord in diabetes. The [³H]AF-DX 384 membrane binding was performed to determine the number and affinity of spinal cord M2 muscarinic receptors in normal and diabetic rats. We found that the antinociceptive effect of intrathecal 2 to 12 µg muscarine in diabetic animals was potentiated significantly compared with that in normal animals. The maximal muscarine-stimulated [³⁵S]GTPS binding was 112.5 ± 8.3% in normal rats and 168.8 ± 12.1% (P < 0.05) in diabetic rats. Although the K_D value (2.9 nM) was similar in both groups, the B_max of [³H]AF-DX 384 membrane binding was significantly higher in diabetic than in normal rats (255.2 ± 5.9 versus 165.9 ± 3.5 fmol/mg protein, P < 0.05). Collectively, these data strongly suggest that the muscarinic receptor is up-regulated in the dorsal spinal cord in diabetic rats. This finding probably accounts for the increased efficacy of the antinociceptive effect of intrathecal muscarinic agonists in diabetic neuropathic pain.

Address correspondence to: Hui-Lin Pan, Department of Anesthesiology, H187, Penn State University College of Medicine, 500 University Drive, Hershey, PA 17033-0850. E-mail: hpan{at}psu.edu

This article has been cited by other articles:

				H.-M. Zhang, H.-Y. Zhou, S.-R. Chen, D. Gautam, J. Wess, and H.-L. Pan Control of Glycinergic Input to Spinal Dorsal Horn Neurons by Distinct Muscarinic Receptor Subtypes Revealed Using Knockout Mice J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 963 - 971. [Abstract] [Full Text] [PDF]

				N. R. Sullivan, L. Leventhal, J. Harrison, V. A. Smith, T. A. Cummons, T. B. Spangler, S.-C. Sun, P. Lu, A. J. Uveges, B. W. Strassle, et al. Pharmacological Characterization of the Muscarinic Agonist (3R,4R)-3-(3-Hexylsulfanyl-pyrazin-2-yloxy)-1-aza-bicyclo[2.2.1]heptane (WAY-132983) in in Vitro and in Vivo Models of Chronic Pain J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1294 - 1304. [Abstract] [Full Text] [PDF]

				X.-L. Wang, H.-M. Zhang, S.-R. Chen, and H.-L. Pan Altered synaptic input and GABAB receptor function in spinal superficial dorsal horn neurons in rats with diabetic neuropathy J. Physiol., March 15, 2007; 579(3): 849 - 861. [Abstract] [Full Text] [PDF]

				H.-M. Zhang, S.-R. Chen, and H.-L. Pan Regulation of Glutamate Release From Primary Afferents and Interneurons in the Spinal Cord by Muscarinic Receptor Subtypes J Neurophysiol, January 1, 2007; 97(1): 102 - 109. [Abstract] [Full Text] [PDF]

				S.-R. Chen and H.-L. Pan Loss of TRPV1-Expressing Sensory Neurons Reduces Spinal {micro} Opioid Receptors But Paradoxically Potentiates Opioid Analgesia J Neurophysiol, May 1, 2006; 95(5): 3086 - 3096. [Abstract] [Full Text] [PDF]

				S.-R. Chen, J. Wess, and H.-L. Pan Functional Activity of the M2 and M4 Receptor Subtypes in the Spinal Cord Studied with Muscarinic Acetylcholine Receptor Knockout Mice J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 765 - 770. [Abstract] [Full Text] [PDF]